# Navigating the Impact of India’s Recent Ban on Fixed-Dose Combinations: A Call for Evidence-Based Regulation

**Authors:** Muhammed Favas KT, Guru Datt Sharma, Sanjit Sah

PMC · DOI: 10.34172/apb.43741 · Advanced Pharmaceutical Bulletin · 2024-09-24

## Full-text entities

- **Diseases:** bacterial infections (MESH:D001424), fungal infections (MESH:D009181), fevers (MESH:D005334), FDCs (MESH:D011681)
- **Chemicals:** FDCs (-), omeprazole (MESH:D009853), dicyclomine (MESH:D004025), paracetamol (MESH:D000082), mefenamic acid (MESH:D008528)
- **Species:** Homo sapiens (human, species) [taxon 9606], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11970505/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC11970505/full.md

---
Source: https://tomesphere.com/paper/PMC11970505